Cargando…

Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells

Immunotherapy targeting glioblastoma initiating cells (GIC) is considered a promising strategy. However, GIC are prone to evade immune response and there is a need for potent adjuvants. IFN-β might enhance the immune response and here we define its net effect on the innate immunogenicity of GIC. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolpert, Fabian, Happold, Caroline, Reifenberger, Guido, Florea, Ana-Maria, Deenen, René, Roth, Patrick, Neidert, Marian Christoph, Lamszus, Katrin, Westphal, Manfred, Weller, Michael, Eisele, Günter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595134/ https://www.ncbi.nlm.nih.gov/pubmed/26441059 http://dx.doi.org/10.1371/journal.pone.0139603

Ejemplares similares

MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM
por: Stojcheva, Nina, et al.
Publicado: (2016)

EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise
por: Westphal, Manfred, et al.
Publicado: (2017)

Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity
por: Lohmann, Birthe, et al.
Publicado: (2020)

MLTI-19. VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH BRAIN METASTASES: THE PICOS SCORE
por: Wolpert, Fabian, et al.
Publicado: (2019)

EGFR Amplification and Glioblastoma Stem-Like Cells
por: Liffers, Katrin, et al.
Publicado: (2015)

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
por: Sievers, Philipp, et al.
Publicado: (2020)

Chimeric Antigen Receptor T Cells in Glioblastoma—Current Concepts and Promising Future
por: Kringel, Rebecca, et al.
Publicado: (2023)

Molecular profiling of an osseous metastasis in glioblastoma during checkpoint inhibition: potential mechanisms of immune escape
por: Mohme, Malte, et al.
Publicado: (2020)

Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma
por: Dührsen, Lasse, et al.
Publicado: (2019)

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
por: Codo, Paula, et al.
Publicado: (2014)

Control of glioma cell migration and invasiveness by GDF-15
por: Codó, Paula, et al.
Publicado: (2016)

PATH-05 Challenge and clinical relevance of a non-matching classifier output in genome-wide DNA methylation analysis for CNS neoplasms in pediatric and adolescent patients
por: Drexler, Richard, et al.
Publicado: (2022)

Venous thromboembolic events in glioblastoma patients: An epidemiological study
por: Eisele, Amanda, et al.
Publicado: (2022)

Chemotherapy for intracranial ependymoma in adults
por: Gramatzki, Dorothee, et al.
Publicado: (2016)

Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro
por: Suwala, Abigail Kora, et al.
Publicado: (2018)

Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
por: Wikman, Harriet, et al.
Publicado: (2012)

Glioma Cell Death Induced by Irradiation or Alkylating Agent Chemotherapy Is Independent of the Intrinsic Ceramide Pathway
por: Gramatzki, Dorothee, et al.
Publicado: (2013)

TBIO-07. Pediatric tumor classification through genome-wide methylation profiling of extracellular vesicle DNA
por: Ricklefs, Franz, et al.
Publicado: (2022)

MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value
por: Leske, Henning, et al.
Publicado: (2023)

Circulating tumor cells and extracellular vesicles as liquid biopsy markers in neuro-oncology: prospects and limitations
por: Westphal,, Manfred, et al.
Publicado: (2022)

Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival
por: Wirsching, Hans-Georg, et al.
Publicado: (2023)

Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients
por: Mock, Andreas, et al.
Publicado: (2015)

Interferon-β sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02
por: Lohmann, Birthe, et al.
Publicado: (2020)

Expression of Eukaryotic Initiation Factor 5A and Hypusine Forming Enzymes in Glioblastoma Patient Samples: Implications for New Targeted Therapies
por: Preukschas, Michael, et al.
Publicado: (2012)

Interferon-Independent Innate Responses to Cytomegalovirus
por: Ashley, Caroline L., et al.
Publicado: (2019)

The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells
por: Mazor, Gal, et al.
Publicado: (2019)

How we treat glioblastoma
por: Weller, Michael, et al.
Publicado: (2019)

Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer
por: Piffko, Andras, et al.
Publicado: (2022)

Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial
por: Vils, Alex, et al.
Publicado: (2021)

EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells
por: Struve, Nina, et al.
Publicado: (2015)

24. LOCAL TUMOR PROGRESSION IS A RISK FACTOR FOR POSTOPERATIVE SEIZURES IN PATIENTS WITH BRAIN METASTASIS
por: Grossenbacher, Bettina, et al.
Publicado: (2020)

Postoperative progression of brain metastasis is associated with seizures
por: Wolpert, Fabian, et al.
Publicado: (2022)

Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
por: Naghavian, Reza, et al.
Publicado: (2023)

Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients
por: Wikman, Harriet, et al.
Publicado: (2014)

Relevance of PTEN loss in brain metastasis formation in breast cancer patients
por: Wikman, Harriet, et al.
Publicado: (2012)

Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability
por: Drexler, Richard, et al.
Publicado: (2023)

Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons
por: Rother, Nils, et al.
Publicado: (2020)

Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models()
por: Blomberg, Evelina, et al.
Publicado: (2022)

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay
por: Belloum, Yassine, et al.
Publicado: (2020)

Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1- and MYBL2-dependent transcriptional activation
por: Hauffe, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fhudmql79nhe7kar96ls6b125e